McHenry
LATEST NEWS
Orsini Launches ORBIT™ (Orsini Rare Business Intelligence Technology) to Enhance Rare Disease Patient Care
ELK GROVE VILLAGE, Ill., Oct. 3, 2024 /PRNewswire/ -- Orsini, a leader in rare disease pharmacy solutions, is proud to announce the launch of ORBIT™ (Orsini Rare Business Intelligence Technology), an advanced artificial intelligence (AI)-enabled reporting and analytics platform designed to enhance patient care for those living with a rare disease. ORBIT leverages the power of AI to provide deeper insights and more personalized support, enabling pharmaceutical manufacturers to better understand and address the unique needs of rare disease patients. By harnessing the latest advancements in technology, ORBIT pairs real-world data collection with robust analytics and reporting capabilities to enable more informed decision-making and enhance patient engagement and adherence. ORBIT is designed for flexibility and agility, using an API-forward approach to exchange real-time data with our pharmacy, patient engagement platforms, manufacturers' systems and other business associates as relevant.
It’s essential to note our commitment to transparency:
Our Terms of Use acknowledge that our services may not always be error-free, and our Community Standards emphasize our discretion in enforcing policies. As a platform hosting over 100,000 pieces of content published daily, we cannot pre-vet content, but we strive to foster a dynamic environment for free expression and robust discourse through safety guardrails of human and AI moderation.